In many countries throughout the world, the incidence of malignant melanoma
is rising rapidly. In the United States in the last 20 years, there has been
an estimated 4% increase per year in incidence and nearly a 2% increase per
year in mortality.1 Another alarming aspect
of melanoma is its frequency in the younger population. In the United States,
about 1 in 4 new cases of melanoma occur in people younger than 40 years,2 and the median age at diagnosis of melanoma is 53
years. This malignancy ranks second among adult cancers (behind adult leukemia)
in potential years of life lost.3
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 12
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
The Rational Clinical Examination
Make the Diagnosis: Melanoma
All results at
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.